Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 18/20 | 1.00 |
| ▸ | G6PD | P11413 | 1/20 | 0.66 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.66 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.66 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.66 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9644532 | 0.90 | ALOX5 (1.00) | ALOX5G6PDALOX15ALOX12PTGS1 | |
| SCHEMBL7536266 | 0.81 | ALOX5 (1.00) | ALOX5G6PDALOX15ALOX12PTGS1 | |
| SCHEMBL31021948 | 0.81 | ALOX5 (0.82) | ALOX5G6PDALOX15ALOX12PTGS1 | |
| SCHEMBL28816190 | 0.81 | ALOX5 (0.82) | ALOX5G6PDALOX15ALOX12PTGS1 | |
| SCHEMBL10947701 | 0.81 | ALOX5 (0.82) | ALOX5G6PDALOX15ALOX12PTGS1 | |
| SCHEMBL2379976 | 0.80 | ALOX5 (1.00) | ALOX5G6PDALOX15ALOX12PTGS1 | |
| Phenidone SCHEMBL235192 | 0.80 | ALOX5 (1.00) | ALOX5G6PDALOX15ALOX12PTGS1 | |
| Phenidone SCHEMBL10904906 | 0.80 | ALOX5 (1.00) | ALOX5G6PDALOX15ALOX12PTGS1 | |
| SCHEMBL7094594 | 0.79 | ALOX5 (0.67) | ALOX5G6PDALOX15ALOX12PTGS1 | |
| SCHEMBL7095931 | 0.79 | ALOX5 (0.66) | ALOX5G6PDALOX15ALOX12PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 130 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114874144-B | Process for preparing 4-bromo-N-arylpyrazole compound | 曲靖师范学院 | 2024-07-05 | — | — | CN | claimed |
| US-4423139-A | SYNERGISTIC MIXTURE OF AROMATIC POLYOL, AROMATIC DIAMINE, OR AROMATIC OXYAMINE WITH 1-PHENYL-3-PYRAZOLIDINONE | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1983-12-27 | — | — | US | claimed |
| EP-3112350-B1 | METHOD FOR PRODUCING PYRAZOLE COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2018-04-04 | — | — | EP | disclosed |
| US-9624177-B2 | Method for producing pyrazole compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-04-18 | — | — | US | disclosed |
| US-20170008853-A1 | METHOD FOR PRODUCING PYRAZOLE COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-01-12 | — | — | US | disclosed |
| EP-3112350-A1 | METHOD FOR PRODUCING PYRAZOLE COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2017-01-04 | — | — | EP | disclosed |
| WO-2007117778-A9 | QUINOLONES USEFUL AS INDUCIBLE NITRIC OXIDE SYNTHASE INHIBITORS | KALYPSYS INC (US) | 2009-05-22 | — | — | WO | disclosed |
| EP-1986747-A2 | QUINOLONES USEFUL AS INDUCIBLE NITRIC OXIDE SYNTHASE INHIBITORS | Kalypsys, Inc. (US) | 2008-11-05 | — | — | EP | disclosed |
| US-20080139558-A1 | QUINOLONES USEFUL AS INDUCIBLE NITRIC OXIDE SYNTHASE INHIBITORS | KALYPSYS, INC. (US) | 2008-06-12 | — | — | US | disclosed |
| WO-2007117778-A2 | QUINOLONES USEFUL AS INDUCIBLE NITRIC OXIDE SYNTHASE INHIBITORS | KALYPSYS, INC. (US) | 2007-10-18 | — | — | WO | disclosed |
| US-4916044-A | STORAGE STABLE, SHARP IMAGES | FUJI PHOTO FILM CO., LTD. (JP) | 1990-04-10 | — | — | US | disclosed |
| US-4201578-A | HYDROQUINONE ESTERS | EASTMAN KODAK COMPANY (US) | 1980-05-06 | — | — | US | disclosed |
| US-4199354-A | BALLASTED IMAGE-DYE PROVIDING MATERIALS | EASTMAN KODAK COMPANY (US) | 1980-04-22 | — | — | US | disclosed |
| US-4199355-A | BALLASTED CHROMOGENS | EASTMAN KODAK COMPANY (US) | 1980-04-22 | — | — | US | disclosed |
| US-4192678-A | DIFFUSION TRANSFER, COLOR PHOTOGRAPHY | EASTMAN KODAK COMPANY (US) | 1980-03-11 | — | — | US | disclosed |
| US-4192679-A | DEVELOPER-SCAVENGER | EASTMAN KODAK COMPANY (US) | 1980-03-11 | — | — | US | disclosed |
| US-4139379-A | Photographic elements containing ballasted electron-accepting nucleophilic displacement compounds | EASTMAN KODAK COMPANY (US) | 1979-02-13 | — | — | US | disclosed |
| US-4126461-A | NONDIFFUSIBLE RESORCINOL COUPLER | EASTMAN KODAK COMPANY (US) | 1978-11-21 | — | — | US | disclosed |
| US-4108850-A | Positive-working immobile photographic azo compounds | EASTMAN KODAK COMPANY (US) | 1978-08-22 | — | — | US | disclosed |
| US-3980479-A | Positive-working immobile photographic compounds which cleave by intramolecular nucleophilic displacement in alkali unless oxidized | EASTMAN KODAK COMPANY (US) | 1976-09-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170008853-A1 | METHOD FOR PRODUCING PYRAZOLE COMPOUND | CBR3, POR, CBR1 | ALOX5 538/4885G6PD 210/4885ALOX15 574/4885 |
| US-20080139558-A1 | QUINOLONES USEFUL AS INDUCIBLE NITRIC OXIDE SYNTHASE INHIBITORS | NOS2, NOS1, NQO2 | ALOX5 318/4885G6PD 63/4885ALOX15 369/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.